Global Information
회사소개 | 문의 | 비교리스트

자가투여 피하 주입 시스템(휴대용)

Self-Administered Ambulatory Subcutaneous Infusion Systems

리서치사 Greystone Research Associates
발행일 2020년 03월 상품 코드 929359
페이지 정보 영문
가격
US $ 2,850 ₩ 3,444,000 PDF by E-mail (Single User License)
US $ 4,500 ₩ 5,438,000 PDF by E-mail (Site License)
US $ 6,500 ₩ 7,855,000 PDF by E-mail (Global License)


자가투여 피하 주입 시스템(휴대용) Self-Administered Ambulatory Subcutaneous Infusion Systems
발행일 : 2020년 03월 페이지 정보 : 영문

자가투여 요법의 채택과 수용이 확대됨에 따라 환자는 의사와 보내는 시간이 감소하고, 치료의 시행과 관리에서 큰 역할을 담당하고 있습니다. 의료 제공의 이 극적인 변화는 환자 친화적 설계 구상에 의한 디바이스의 필요성을 창출하고 있습니다.

자가투여 피하 주입 시스템(휴대용 : Self-Administered Ambulatory Subcutaneous Infusion Systems)에 대해 조사분석했으며 디바이스의 상세 내역, 대상 시장, 과제, 수요 촉진요인, 영향 등에 관한 정보를 정리하여 전해드립니다.

목차

개요

주사제/주입제 시장 부문 동향

  • 의약품 개발 동향
  • 약물 전달 기기의 진화
  • 환자의 자기 관리를 향한 동향
  • 실현 기술
  • 동결건조약/재구성

피하 주입 시스템 - 설계 요인

  • 양과 점도
  • 1차 포장
  • 주입 방법
  • 디바이스 일렉트로닉스

피하 주입 디바이스 - 시장 부문

  • 외래 환자의 주입 비용·물류 부담
  • 생물제제
  • 고용량 약물
  • 기간 의존 투여 약물

피하 주입 시스템 디바이스 분석

  • enFuse
  • Libertas
  • Evolve
  • SensePatch
  • SmartDose
  • SmartDose Preloaded
  • YpsoDose
  • E3D Patch Pump
  • Pod

시장 요인

  • 자기 관리와 환자 컴플라이언스(Patient Compliance)
  • 규제 가이던스 및 제품 승인
  • 의료의 경제
  • 제제의 차별화

시장 참여 기업 개요

KSA 20.04.20

Converging Factors Driving the Growth of Subcutaneous Infusion

As currently formulated, a significant number of therapeutic drugs require dosage volumes or possess viscosities well in excess of the upper range for traditional subcutaneous delivery. These drugs are currently delivered via infusion. The demographics of patient populations and the current trend in therapeutic drug development are converging to create an increasingly steep demand curve for infusion. The costs and logistics of this convergence are a major driver of the energy behind small form factor subcutaneous infusion systems. As the adoption of and acceptance of self-administered therapies grows, patients are spending less time with physicians and are playing a greater role in the delivery and management of their treatments. This dramatic shift in healthcare delivery is creating a need for devices that mask an underlying layer of complexity via design initiatives that are patient-friendly.

What You Will Learn:

  • What ambulatory subcutaneous infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
  • What are the therapeutic markets being targeted by ambulatory subcutaneous infusion systems?
  • What are the essential design factors, material selection issues, technologies and market development issues for ambulatory subcutaneous infusion systems?
  • What are the major factors that will drive ambulatory subcutaneous infusion systems demand?
  • What is the addressable market for subcutaneous infusion systems?
  • What is the expected impact of subcutaneous infusion systems on drug delivery markets?
  • Who are the significant players in this segment? What are their strategies? Who are their alliance partners?

Table of Contents

Executive Summary

Injectable/Infusible Market Segment Dynamics

  • Drug Development Trends
  • Drug Delivery Device Evolution
  • The Trend toward Patient Self-Administration
  • Enabling Technology
  • Lyophilized Drugs/Reconstitution

Subcutaneous Infusion Systems - Design Factors

  • Volumes and Viscosities
  • Primary Packaging
  • Injection Method
  • Device Electronics

Subcutaneous Infusion Devices - Market Segments

  • The Cost and Logistical Burden of Out-patient Infusion
  • Biologicals
  • High Volume Drugs
  • Duration Dependent Administration Drugs

Subcutaneous Infusion Systems Device Analysis

  • enFuse
  • Libertas
  • Evolve
  • SensePatch
  • SmartDose
  • SmartDose Preloaded
  • Unbranded Device
  • Unbranded Device
  • YpsoDose
  • E3D Patch Pump
  • Pod

Market Factors

  • Self-Administration and Patient Compliance
  • Regulatory Guidance and Product Approvals
  • Healthcare Economics
  • Drug Product Differentiation

Market Participant Profiles

Back to Top
전화 문의
F A Q